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beams were acceptable within the clinical tolerances of this 
institution: ≥95% of points passed a gamma analysis of 3%/3mm and 
PTV point dose within 2% of calculations. The treatment delivery 
times for the 6XFFF plans were approximately 1min faster than the 6X 
treatments. 
 
Parameter Units Average Values 
  6X 6XFFF 
PTV Volume CC (14.65 - 40.50) 
Dose to 95% of PTV Gy 55.1 55.1 
Dose to 99% of PTV Gy 53.4 53.2 
R100  1.13 1.12 
R50  5.18 5.01 
Dose@2cm Gy 31.6 31.4 
Mean lung Dose Gy 3.1 3.1 
V 20 Lung % 3.6 3.4 
Max. PTV Dose Gy 70.0 69.5 
Total MU  1657 2071 
Beams / segments  50 52 
Delivery time sec 175 108 
Table 1: Comparison of 6X and 6XFFF plans produced on Monaco. 
 
Conclusions: The use of FFF beams for lung VMAT SABR produces 
plans of comparable quality to those produced by flattened beams and 
have the advantage of decreased delivery times, even with a mid-line 
isocentre technique. The VMAT optimisation parameters did not alter 
significantly from those used for flattened beams and therefore 
implementation of FFF beams requires minimal changes to the 
established planning process. 
*1: Elekta AB, Sweden. 
*2: ScandiDos AB, Sweden. 
*3: ComputerizedImaging Reference Systems Inc, USA. 
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Purpose/Objective: To compare the planning target volume (PTV) 
coverage and the dose distribution to normal tissues in mediastinal 
Hodgkin’s disease (HD) patients, treated with 30Gy, using four 
different techniques: Three Dimensional Conformal RadiationTherapy 
(3D-CRT), Intensity Modulated Radiation Therapy (IMRT), Volumetric 
Modulated Arc Therapy (VMAT) and Helical Tomotherapy (HT). 
Materials and Methods: 10 patients with Stage II A-B HD were 
historically treated with involved-field 3D-CRT. Two experimental 
plans were calculated for each technique for each single patient: the 
first optimized for PTV coverage, the second for reduction of lung 
doses. IMRT static fields plans were evaluated both with a 5 and an 8 
field combination. Therefore 9 plans were calculated for each 
patient. The optimal PTV coverage was considered D95 and D98 > 95% 
of dose prescription; the optimal dose constraints for the lungs were 
considered V20 <20% and V5<50%. The doses to PTV and to organs at 
risk (lungs, heart, spinal cord and esophagus) were compared. A direct 
comparison of the different plans was performed. The best of the 
experimental plans was then compared with the plan used to treat the 
patient. Differences were considered statistically significant if p<0.01 
(T-student test for paired data). 
Results: 8 fields IMRT, compared to 5 fields one, allows similar target 
coverage and significant dose reduction to the lungs(p<0,005). VMAT 
plans, as 8 fields-IMRT, guarantees PTV coverage when the goal is the 
lung doses reduction, but with more dose conformation to target. 
Lung and esophagus doses with HT are lower than with VMAT 
(p<0,005). Compared with 3D-CRT, HT provides a better PTV coverage 
(p<0.005) and a lower dose to the spinal cord (p<0.005). About the 
lungs, only 3D-CRT allows to respect the constraints for low doses (V5 
<50%) (p <0.005) but with the inconvenient of an increase in high 
doses regions (V20 and V30); HT shows instead a significant advantage 
in V20 and V30 values but with significant worse V5 (p<0,005). The 
statistical differences in OAR dose distribution and PTV coverage of 
3DCRT versus HT (PTV coverage and lung optimization) are shown in 
Tab1. 
 
Tab 1 (better values in bold) 
  3DCRT HT PTV 
coverage 
p HT lung 
optimization  
p 
PTV Dmax 32.2 
Gy 
31Gy <0.005 31.1 Gy <0.005
D95 28 Gy 29.4 Gy <0.005 29.1 Gy <0.001
D98 27 Gy 29 Gy <0.005 28.5 Gy n.s. 
spinal 
cord 
Dmax 30.1 
Gy 
22.2 Gy <0.005 22.4 Gy <0.005
Lung V5 37.6% 52.2% <0.005 47.9% <0.01 
V20 18.1% 11.6% <0.005 11.3% <0.005
V30 1.5% 0.1% <0.005 0.1% <0.005
Heart Dmax 30.5 
Gy 
30.4 Gy n.s. 30.5 Gy n.s. 
Davg 10.5 
Gy 
9.4 Gy n.s.  9.4 Gy n.s.  
Esophagus Dmax 29.7 
Gy 
30.4 Gy n.s. 30.4 Gy n.s. 
Davg 19.5 
Gy 
15.6 Gy n.s.  15.8 Gy n.s. 
CI D95 3.3 1.5  <0.005 1.5  <0.005
 
Conclusions: The dose distributions obtained with HT seem to be 
better than with the other techniques, allowing a high target coverage 
and a reduction of high doses to lungs and spinal cord. However it is 
necessary to evaluate the late effects of larger volumes exposed to 
low doses, in long-term survivors. 
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Purpose/Objective: To compare the planning target volume (PTV) 
coverage and the dose distribution to normal tissues in patients with 
lung cancer, treated, after surgery, on mediastinal lymph nodes, using 
four different techniques: Three Dimensional Conformal Radiation 
Therapy(3D-CRT), Intensity Modulated Radiation Therapy (IMRT), 
Volumetric ModulatedArc Therapy (VMAT) and Helical Tomotherapy 
(HT). 
Materials and Methods: 9 patients with lung cancer treated after 
surgery on mediastinal lymph-nodes were selected, 5 with a dose 
prescription of 50.4 Gy (1.8 Gy/fraction) and 4 with a dose 
prescription of 50 Gy (2 Gy/fraction). For each technique we 
calculated two plans: the first optimized for PTV coverage and the 
second for lung doses reduction. The optimal PTV coverage was 
considered D95and D98 > 95% of dose prescription; the optimal dose 
constrains for the lungs were considered V20 <20% and V5<50% . IMRT 
static fields plans were evaluated both with a 5 and an 8 field 
combination. For tomotherapy plans optimized for the reduction of 
lung doses, one plan was calculated with a collimation width of 1 cm 
(the other ones have a collimation width of 2.5 cm).Therefore 10 
plans were calculated for each patient. The doses to PTV andorgans at 
risk were compared. The best of the experimental plan was then 
compared with the plan used to treat the patient. Differences were 
considered statistically significant if p<0.01 (T-student test for paired 
data). 
Results: IMRT with 8 fields, compared to IMRT with 5 fields, allows to 
get better PTV coverage and to reduce lung doses (p<0.05). With 
VMAT the lung V20 and V30 are smaller than those obtained with 
IMRT(p<0.05), but VMAT does not allow to maintain PTV coverage. 
Tomotherapy allows to reduce high doses to the organs at risk, but at 
the expense of larger lung V5. With 3D-CRT lung doses respect the 
limits imposed, but PTV coverage is worse than that obtained with 
IMRT. A statistical correlation demonstrated that there is a direct 
correlation between 'PTV length/lung length' ratio and lungs V5 for 
3D-CRT, IMRT with 8 fields and VMAT plans and there is an inverse 
correlation between 'PTV length-lung length' ratio and PTV D95 
forTomotherapy plans. (Tab 1) 
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Conclusions: IMRT with 8 fields is the best technique to obtain the 
goals of the optimization. VMAT can be used when the 'PTV length-
lung length' ratio is low. Tomotherapy doesn’t allow to maintain an 
acceptable PTV coverage if the ratio is high. 
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Purpose/Objective: APBI with external beam RT (EBRT) has emerged 
in the recent years as a treatment option for selected patients with 
early stage breast cancer. Some studies demonstrated the feasibility 
of using volumetric modulated arc therapy (VMAT) for APBI as away to 
improve PTV dose conformity and to deliver lower doses to the 
ipsilateral lung and breast as compared to the conventional 3D-CRT 
techniques. Separately, multiple studies have confirmed the 
effectiveness of breath hold techniques in reducing the cardiac dose 
for left sided breast cancer treated with EBRT. In the search of an 
optimal APBI treatment procedure, we investigate the use of VMAT 
(RapidArc®) and/or voluntary moderately deep inspiration breath hold 
(vmDIBH) in patients treated with external beam APBI.  
Materials and Methods: Three patients were included in this study. 
For each patient 2 CT scans were made, one in free breathing (FB) 
and one in vmDIBH. In each scan, five different tumours were 
contoured in the left breast: upper inner, upper outer, central, lower 
inner, and lower outer. On each CT scan, a conventional 3D-CRT and a 
RapidArc® plan were made using the Varian EclipseTM treatment 
planning system, leading to 60 combinations of patient, tumour site 
and technique. Dose parameters for the PTV, heart, lungs, breasts 
were compared for all plans.  
Results: Preliminary results of this ongoing study show that the 
highest cardiac doses were observed in 3D-CRT plans combined with 
FB for tumors located in the lower inner part of the breast [mean dose 
3.7 ± 0.7 Gy]. With vmDIBH these values were reduced to 1.8± 0.3 Gy. 
The heart volume receiving > 5Gy (V5Gy) was reduced to 7.8% for 
RapidArc® plans in vmDIBH compared with 24.7% and 14.7% in 3D-CRT 
plans in FB and with vmDIBH respectively. For other tumour positions, 
the mean heart dose ranged from 0.2 Gy to 1.3 Gy in FB, which is 
always slightly reduced using vmDIBH to a maximum of 0.5 Gy in all 
plans. RapidArc® plans in breath hold also slightly decreased the 
ipsilateral lung doses [V5Gy= 12.6% ± 1.2%] compared to 3D-CRT 
plans[V5Gy = 15.8% ± 7.3%]. The fraction of the non-target part of the 
ipsilateral breast receiving 50% of the prescribed dose or more was on 
average reduced by 30% in RapidArc® plans as opposed to 3D-CRT 
plans. While, no dose was given to the contralateral breast in 3D-CRT 
plans, RapidArc® plans showed a slight increase in the low dose [V5Gy = 
2.3% ± 0.6%]. In all RapidArc®plans the dose conformity was better 
compared with that of 3D-CRT plans [CI =0.9 ± 0.05 vs. 0.7 ± 0.08]. 
Conclusions: APBI with RapidArc® offers good PTV dose conformity 
and delivers lower doses to lungs and ipsilateral breast compared to 
3D-CRT. This has been at the cost of slightly higher volumes of 
contralateral breast receiving low dose radiation. Patients with 
tumours in the lower inner part of the breast are most likely to 
benefit from combined VMAT and breath hold techniques.  
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Purpose/Objective: Although a lot of tools are available in modern 
treatment planning systems to evaluate 3D dose distributions (DVH, 
biological indices, isodoses in arbitrary planes), the optimality of a 
given IMRT/VMAT plan still depends mainly on the experience of the 
planner and on the way that the optimization problem has been 
formulated in terms of dose objectives. To overcome this bias, we 
have implemented a system that uses our experience in IMRT 
optimization to predict final organ-at-risk (OAR) dose based on 
individual patient geometry. With this technique, we can detect and 
evaluate deviations between predicted and planner results, or 
automatically generate plans with OAR doses consistent with our past 
clinical experience. 
Materials and Methods: In this study we focused on prostate cancer. 
We reviewed all photon IMRT/VMAT plans treated in the past two 
years and found that the final equivalent uniform dose (EUD) for 
bladder and rectum showed a strong linear correlation with the 
overlap volume with the PTV. We used the overlap volume to predict 
plan optimization objectives for rectum and bladder EUD. These 
actions were implemented by user-scripting in our treatment planning 
system (Philips Pinnacle3). This automated technique was applied on 
23 patients to be treated for a prostate cancer in our institution. 
Results: Although they respected clinical goals, significant deviations 
between the operator's final plan and the automated plan (EUD>2Gy) 
were observed in 6 cases indicating non-optimal plans in comparison 
to our past experience. This approach permitted to reduce by half in 
average the planning time, mainly be reducing the number of manual 
iterations loops which are often needed to achieve good quality plans. 
Conclusions: The implementation of this experience-based IMRT 
quality control step has shortened the treatment planning time and 
enables us to easily detect bad optimizations compared to previously 
treated plans. The planner has now the ability to quickly evaluate 
quality of its plan incomparison to previously treated plans. We plan 
to extend this approach to other clinical sites. 
 POSTER: PHYSICS TRACK: TREATMENT PLAN 
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Purpose/Objective: Increasing the dose delivered via IMRT planning; 
specifically patient specific dose escalation is of current clinical 
interest in improving local control and in turn survival in NSCLC 
patients. Dose escalation usually requires a plan to be created for 
each feasible prescription until an OAR constraint can not be met or a 
plan is optimised using the maximum prescription. To identify the 
optimum prescription for a patient requires a significant amount of 
planning time and the manual creation of multiple redundant plans. 
This study aims to investigate the effectiveness of an automated IMRT 
planning technique in reducing the planning time required by 
minimising the number of plans being created manually.  
Materials and Methods: The automated planning system is operated 
using an in house written java program. Constraints used for inverse 
plan optimisation in Pinnacle v9.0 are iteratively changed using the 
java program. The resulting plan is compared against a static group of 
evaluation objectives to ensure suitability. Clinically relevant 
constraints chosen for optimisation are placed into several levels of 
precedence. Tumour coverage is given the initial priority followed by 
serial organ near-max doses. Once a suitable plan is created the 
system increases the prescription dose and the optimisation is 
repeated using the constraints from the previous iteration as a 
starting point. Figure 1 demonstrates the process used by the system. 
The initial prescription dose of 55.8Gy is increased by adding 
additional fractions of 1.8Gy. The treatment schedule is bi-daily over 
a 4 week period. Dose escalation continues until a maximum 
prescription dose of 79.2Gy is achieved or an OAR objective cannot be 
met. This technique was evaluated by applying it to 5 NSCLC patients. 
Evaluation objectives were selected from an isotoxic lung feasibility 
study. In addition to the evaluation of the dose statistics using a plan 
